Aperio Group’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $600K | Buy |
45,669
+12,007
| +36% | +$158K | ﹤0.01% | 1870 |
|
|
2020
Q3 | $325K | Buy |
33,662
+641
| +2% | +$6.19K | ﹤0.01% | 2036 |
|
|
2020
Q2 | $378K | Buy |
33,021
+8,392
| +34% | +$96.1K | ﹤0.01% | 1908 |
|
|
2020
Q1 | $255K | Buy |
24,629
+7,405
| +43% | +$76.7K | ﹤0.01% | 1994 |
|
|
2019
Q4 | $283K | Buy |
17,224
+4,904
| +40% | +$80.6K | ﹤0.01% | 2088 |
|
|
2019
Q3 | $164K | Buy |
12,320
+2,649
| +27% | +$35.3K | ﹤0.01% | 2197 |
|
|
2019
Q2 | $136K | Sell |
9,671
-800
| -8% | -$11.3K | ﹤0.01% | 2299 |
|
|
2019
Q1 | $193K | Sell |
10,471
-971
| -8% | -$17.9K | ﹤0.01% | 2174 |
|
|
2018
Q4 | $299K | Buy |
+11,442
| New | +$299K | ﹤0.01% | 1947 |
|